Release date: 2006-09-19 Xinjiang has made a major breakthrough in the implementation of bone marrow transplantation for the treatment of leukemia ----------------------------------------- ---------------------------------------
Goji Berry ( [Goji" means [happy") , also called wolfberry, has been used for thousands of years by herbalists in China to protect the liver, help eyesight, boost immune function, improve circulation, and promote longevity and overall well being. It has only recently gained popularity in the west, it has become so polar, in fact, the Time Magazine recently named the Goji berry as [super-fruit" of the year. A big reason why Goji berries have quickly become a favorite nutritional supplement is that its impressive list of ingredients. The Goji berry, also called the wolfberry, is a bright purplish red or purple red berry that comes from a shrub that is native to China. In Asia, goji berries have been eaten for generation in the hope of living longer.
Grade C Goji Berry,Grade C Dried Goji Berry,Grade C Wolfberry,C Grade Dried Goji Berries ZHONGNING JIDING BIO SCIENCE DEVELOPMRNT CO., LTD. , https://www.jidinggouqi.com
At the turn of the summer and autumn, Professor Wen Bingzhao, the First Affiliated Hospital of Xinjiang Medical University, led the research team to implement the bone marrow transplantation between parents and children to treat leukemia successfully. So far, 10 new patients have been obtained by this method, and the survival rate has reached the highest level of similar surgery in the country.
It is understood that bone marrow transplantation is the most effective way to treat leukemia. But before, the bone marrow needed for leukemia patients came from the siblings of the patients, and the success rate was only 25%. Except for brothers and sisters, the ratio of matching bone marrow in unrelated volunteers was less than one in 100,000.
According to the data provided by the China Marrow Bank, the number of volunteers for bone marrow donation in the country is about 360,000, and there are only 1900 volunteers in Xinjiang. Wen Bingzhao said: "The achievement of bone marrow transplantation between parents and children has achieved the greatest possibility for relatives (parents, children, cousins, cousins, etc.) to find bone marrow donors."
Leukemia, a blood cancer, is one of the common tumors. It is called a "child killer". The incidence rate is among the highest incidence of malignant tumors in children in China. The incidence rate of children under 15 years old is about 100,000, accounting for all malignant tumors in this age group. 35%, especially children between the ages of 2 and 7.
The research team led by Wen Bingzhao began research on the treatment of leukemia by human leukocyte antigen (HLA) semi-matched peripheral blood stem cell transplantation in 2002, aiming to break through the immunological obstacles in the transplantation of "human leukocyte antigen incompatibility". . In the past 4 years since the start of the research, prevention and treatment measures have been formed in the prevention of transplant rejection. Among the 12 patients who have undergone treatment, 10 have survived without disease, and 9 of them have survived without disease for more than 1 to 4 years. .
—— Information from: Xinhuanet